Mellstedt H - Search Results

1

Immunization effect of monoclonal antibodies against tumor-associated antigens during cancer treatment.

Fagerberg J, Frödin JE, Ragnhammar P, Steinitz M, Wigzell H, Mellstedt H. Fagerberg J, et al. Among authors: mellstedt h. Ann N Y Acad Sci. 1993 Aug 12;690:337-9. doi: 10.1111/j.1749-6632.1993.tb44023.x. Ann N Y Acad Sci. 1993. PMID: 8368748 No abstract available.

2

The clinical significance of HAMA in patients treated with mouse monoclonal antibodies.

Frödin JE, Lefvert AK, Mellstedt H. Frödin JE, et al. Among authors: mellstedt h. Cell Biophys. 1992 Aug-Dec;21(1-3):153-65. doi: 10.1007/BF02789485. Cell Biophys. 1992. PMID: 1285327

3

Cytotoxic functions of blood mononuclear cells in patients with colorectal carcinoma treated with mAb 17-1A and granulocyte/macrophage-colony-stimulating factor.

Ragnhammar P, Masucci G, Frödin JE, Hjelm AL, Mellstedt H. Ragnhammar P, et al. Among authors: mellstedt h. Cancer Immunol Immunother. 1992;35(3):158-64. doi: 10.1007/BF01756182. Cancer Immunol Immunother. 1992. PMID: 1638551 Free PMC article.

4

Therapy of colorectal carcinoma with monoclonal antibodies (MAb17-1A) alone and in combination with granulocyte monocyte-colony stimulating factor (GM-CSF).

Mellstedt H, Frödin JE, Ragnhammar P, Masucci G, Ljungberg A, Hjelm AL, Fagerberg J, Lindemalm C, Osterborg A, Wersäll P, et al. Mellstedt H, et al. Acta Oncol. 1991;30(8):923-31. doi: 10.3109/02841869109088245. Acta Oncol. 1991. PMID: 1777244

5

Anti-idiotypic immunity as a potential regulator in myeloma and related diseases.

Holm G, Bergenbrant S, Lefvert AK, Yi Q, Osterborg A, Mellstedt H. Holm G, et al. Among authors: mellstedt h. Ann N Y Acad Sci. 1991 Dec 30;636:178-83. doi: 10.1111/j.1749-6632.1991.tb33449.x. Ann N Y Acad Sci. 1991. PMID: 1793208 Review.

6

T cell V-gene usage in man in some normal and abnormal situations.

Wigzell H, Grunewald J, Tehrani M, Esin S, Mellstedt H, Osterborg A, Dersimonian H, Brenner M, Ahlberg R, Lefvert AK, et al. Wigzell H, et al. Among authors: mellstedt h. Ann N Y Acad Sci. 1991 Dec 30;636:9-19. doi: 10.1111/j.1749-6632.1991.tb33433.x. Ann N Y Acad Sci. 1991. PMID: 1793233 Review. No abstract available.

7

Chemotherapy and immunotherapy of colorectal cancer.

Masucci G, Ragnhammar P, Frödin JE, Hjelm AL, Wersäll P, Fagerberg J, Osterborg A, Mellstedt H. Masucci G, et al. Among authors: mellstedt h. Med Oncol Tumor Pharmacother. 1991;8(3):207-20. doi: 10.1007/BF02987181. Med Oncol Tumor Pharmacother. 1991. PMID: 1803182 Review.

8

Establishment of idiotype bearing B-lymphocyte clones from a patient with monoclonal gammopathy.

Osterborg A, Steinitz M, Lewin N, Bergenbrant S, Holm G, Lefvert AK, Mellstedt H. Osterborg A, et al. Among authors: mellstedt h. Blood. 1991 Nov 15;78(10):2642-9. Blood. 1991. PMID: 1824258 Free article.

9

Predominant T cell receptor V gene usage in patients with abnormal clones of B cells.

Janson CH, Grunewald J, Osterborg A, DerSimonian H, Brenner MB, Mellstedt H, Wigzell H. Janson CH, et al. Among authors: mellstedt h. Blood. 1991 Apr 15;77(8):1776-80. Blood. 1991. PMID: 1901744 Free article.

10

Peripheral blood T lymphocytes in patients with monoclonal gammopathies: expanded subsets as depicted by capacity to bind to autologous monoclonal immunoglobulins or reactivity with anti-V gene-restricted antibodies.

Osterborg A, Janson CH, Bergenbrant S, Holm G, Lefvert AK, Wigzell H, Mellstedt H. Osterborg A, et al. Among authors: mellstedt h. Eur J Haematol. 1991 Sep;47(3):185-91. doi: 10.1111/j.1600-0609.1991.tb01553.x. Eur J Haematol. 1991. PMID: 1915801

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

446 results

Search Page

Filters